Form 4: CalciMedica Officer Hebbar Sudarshan Reports Stock Option Grant
SEC Filing
CalciMedica's Chief Medical Officer, Sudarshan Hebbar, reports the acquisition of stock options.
Summary
- Sudarshan Hebbar, Chief Medical Officer of CalciMedica, Inc., filed a Form 4 with the SEC.
- The filing reports the grant of employee stock options.
- Hebbar acquired options to purchase 175,000 shares of CalciMedica common stock at an exercise price of $1.53 per share on April 23, 2025.
- The options vest in equal monthly installments over a four-year period, beginning March 26, 2025, with final expiration on April 22, 2035.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, which is neither particularly positive nor negative.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock option grant aligns the interests of the Chief Medical Officer with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Vesting of options begins in equal monthly installments over four years |
| 04/23/2025 | Date of the stock option grant |
| 04/25/2025 | Date of the Form 4 filing |
| 04/22/2035 | Expiration date of the stock options |
Keywords
Form 4, Stock Options, CalciMedica, Officer, Hebbar, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.